The Defense Health Agency intends to award a sole source firm-fixed-price purchase order to Fenwal, Inc. for FDA Fenwal Amicus Apheresis Reagents, as Fenwal is the sole manufacturer and only source capable of meeting the government’s requirements. The supplies support blood platelet collection and pathogen reduction operations for Naval Hospital Okinawa, Japan, and will be delivered to DLA Troop Support XDock West Project in Ontario, CA. The delivery period is 1 October 2026 through 30 September 2027. This notice is not a request for competitive quotes, but interested parties may submit a capability statement for consideration.